Patent ID: 8247174

Claim:
A method of diagnosing or providing a prognosis for endometriosis, the method comprising the steps of: (i) obtaining a biological sample from a human subject suspected of or having endometriosis, (ii) detecting in the biological sample altered expression (over or under expression of at least 50% compared to a subject without endometriosis) of a gene or protein, wherein said altered expression is selected from the group consisting of: under expression of monoamine oxidase A (MAOA) gene or protein, under expression of dickkopf homolog 1 (DKK1) gene or protein, under expression of chemokine ligand 13 (CXCL13, B-cell chemoattractant) gene or protein, under expression of metallothionein 1G (MT1G) gene or protein, under expression of metallothionein 1F (MT1F) gene or protein, under expression of secreted phosphoprotein 1 (SPP1, osteopontin) gene or protein, under expression of glutathione peroxidase 3 (GPX3) gene or protein, and under expression of protein tyrosine phosphatase receptor type R (PTPRR) gene or protein, wherein the altered expression correlates with the diagnosis or prognosis for endometriosis, and (iii) providing a diagnosis or prognosis for endometriosis.